Emily Levitan

Emily Levitan is a Professor of Epidemiology at the University of Alabama at Birmingham (UAB), School of Public Health. She holds multiple appointments across UAB, including roles in the Graduate School, School of Medicine, and various research centers such as the Center for AIDS Research and the Center for Clinical and Translational Science. Her research focuses on cardiovascular disease prevention, long-term effects of HIV and COVID-19, and leveraging administrative data to improve public health outcomes. She leads projects like the REGARDS-MI study and the Deep South SARS-CoV-2 Recovery Cohort, contributing to the NIH RECOVER Initiative on long COVID. Dr. Levitan also serves as Vice Chairperson of the Epidemiology Department at UAB.

• Education: Doctor of Science in Epidemiology (Harvard University, 2006), Master of Science in Epidemiology (Harvard University, 2004), Bachelor of Science in Mathematics/Chemistry (Brown University, 2000).
• Research Interests: Cardiovascular epidemiology, HIV/AIDS, long-term sequelae of infectious diseases, health disparities, and administrative data utilization.

Her recent work emphasizes the role of social determinants in health outcomes, such as comorbidity patterns in heart failure and the impact of adverse childhood experiences on asthma in sickle cell disease patients. Dr. Levitan has secured extensive funding from NIH, CDC, and other agencies, totaling over 76 grants, including studies on HIV testing strategies and cardiovascular biomarkers.

Key collaborations involve multi-center initiatives like the RECOVER Cohort and the C4R study, which classify outcomes of acute and post-acute SARS-CoV-2 infections. Her research also addresses disparities in healthcare access and medication adherence among vulnerable populations.